More

    BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals



    [
    BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals
    [og_img]
    https://www.investing.com/news/stock-market-news/biontech-takes-over-curevac-in-125-billion-allstock-deal-among-covid-rivals-4093447


    Reuters

    Latest articles

    spot_imgspot_img

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img